A rational design to create hybrid β-sheet breaker peptides to inhibit aggregation and toxicity of amyloid-β

No abstract is available for this paper.

• Publication year

  2011

• Venue

  MedChemComm

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/C0MD00213E
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's disease: strategies for disease modification

  2010cited by this paper
• Computational selection of inhibitors of Abeta aggregation and neuronal toxicity.

  2009cited by this paper
• Amyloid-β Peptide (Aβ) Neurotoxicity Is Modulated by the Rate of Peptide Aggregation: Aβ Dimers and Trimers Correlate with Neurotoxicity

  2008cited by this paper
• 3D structure of Alzheimer's amyloid-β(1–42) fibrils

  2005cited by this paper
• Structure and orientation of peptide inhibitors bound to beta-amyloid fibrils.

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-beta(1-42) fibrils.

  2005cited by this paper
• β-sheet breaker peptide prevents Aβ-induced spatial memory impairments with partial reduction of amyloid deposits

  2004cited by this paper
• Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity.

  2003cited by this paper
• The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease.

  2003cited by this paper
• Pharmacological Profiles of Peptide Drug Candidates for the Treatment of Alzheimer's Disease*

  2003cited by this paper
• Novel oxazolidinone-quinolone hybrid antimicrobials.

  2003cited by this paper
• Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide

  2002cited by this paper
• Mapping of possible binding sequences of two beta-sheet breaker peptides on beta amyloid peptide of Alzheimer's disease.

  2002cited by this paper
• Inhibition of amyloid-β-induced cell death in human brain pericytes in vitro

  2002cited by this paper
• Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.

  2000cited by this paper
• Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization.

  2000cited by this paper
• β-Amyloid Peptides Are Cytotoxic to Astrocytes in Culture: A Role for Oxidative Stress

  2000cited by this paper
• An Enzyme-Bound Bisubstrate Hybrid Inhibitor of Adenylosuccinate Synthetase.

  1999cited by this paper
• β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy

  1998cited by this paper
• Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein

  1997cited by this paper
• Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.

  1996cited by this paper
• Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*)

  1996cited by this paper
• Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

  1995cited by this paper
• T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions.

  1995cited by this paper
• Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.

  1995cited by this paper
• Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1.

  1994cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

  1993cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper

• Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis

  2023cites this paper
• Small Molecule Inhibitors for Amyloid Aggregation

  2021cites this paper
• A green fluorescent protein chromophore analogue to promote self-assembly of diphenylalanine into fluorescent microtubes

  2021cites this paper
• Molecular Insights into Destabilization of Alzheimer’s Aβ Protofibril by Arginine Containing Short Peptides: A Molecular Modeling Approach

  2019cites this paper
• CLPFFD-PEG functionalized NIR-absorbing hollow gold nanospheres and gold nanorods inhibit β-amyloid aggregation.

  2018cites this paper
• Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers

  2018cites this paper
• Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer’s Disease

  2015cites this paper
• A comparative study on the self‐assembly of an amyloid‐like peptide at water–solid interfaces and in bulk solutions

  2015cites this paper
• Amyloid formation and inhibition of an all-beta protein: A study on fungal polygalacturonase

  2014cites this paper